140 related articles for article (PubMed ID: 25961950)
1. TCF4 Is a Molecular Target of Resveratrol in the Prevention of Colorectal Cancer.
Jeong JB; Lee J; Lee SH
Int J Mol Sci; 2015 May; 16(5):10411-25. PubMed ID: 25961950
[TBL] [Abstract][Full Text] [Related]
2. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
3. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
4. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
5. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
6. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
[TBL] [Abstract][Full Text] [Related]
7. The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression.
Gonçalves V; Matos P; Jordan P
RNA; 2008 Dec; 14(12):2538-49. PubMed ID: 18952824
[TBL] [Abstract][Full Text] [Related]
8. LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer.
Kriegl L; Horst D; Reiche JA; Engel J; Kirchner T; Jung A
J Transl Med; 2010 Nov; 8():123. PubMed ID: 21092222
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
Parr C; Mirzaei N; Christian M; Sastre M
FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
[TBL] [Abstract][Full Text] [Related]
11. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
Tian W; Han X; Yan M; Xu Y; Duggineni S; Lin N; Luo G; Li YM; Han X; Huang Z; An J
Biochemistry; 2012 Jan; 51(2):724-31. PubMed ID: 22224445
[TBL] [Abstract][Full Text] [Related]
12. The kinase TNIK is an essential activator of Wnt target genes.
Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
14. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
15. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.
Eichhoff OM; Weeraratna A; Zipser MC; Denat L; Widmer DS; Xu M; Kriegl L; Kirchner T; Larue L; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2011 Aug; 24(4):631-42. PubMed ID: 21599871
[TBL] [Abstract][Full Text] [Related]
16. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
17. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.
Hikasa H; Sokol SY
J Biol Chem; 2011 Apr; 286(14):12093-100. PubMed ID: 21285352
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of human TCF4 (TCF7L2) proteins attenuates inhibition by the HBP1 repressor and induces a conformational change in the TCF4::DNA complex.
Elfert S; Weise A; Bruser K; Biniossek ML; Jägle S; Senghaas N; Hecht A
PLoS One; 2013; 8(4):e61867. PubMed ID: 23613959
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells.
Nishimoto A; Kugimiya N; Hosoyama T; Enoki T; Li TS; Hamano K
Int J Oncol; 2014 Jun; 44(6):2077-84. PubMed ID: 24718784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
